These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
133 related items for PubMed ID: 1532902
1. Regulation of transforming growth factor gene expression in human endometrial adenocarcinoma cells. Murphy LJ, Gong Y, Murphy LC. J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):309-14. PubMed ID: 1532902 [Abstract] [Full Text] [Related]
2. Transforming growth factor gene expression in human endometrial adenocarcinoma cells: regulation by progestins. Gong Y, Anzai Y, Murphy LC, Ballejo G, Holinka CF, Gurpide E, Murphy LJ. Cancer Res; 1991 Oct 15; 51(20):5476-81. PubMed ID: 1833051 [Abstract] [Full Text] [Related]
3. Hormonal regulation of proliferation and transforming growth factors gene expression in human endometrial adenocarcinoma xenografts. Gong Y, Murphy LC, Murphy LJ. J Steroid Biochem Mol Biol; 1994 Jul 15; 50(1-2):13-9. PubMed ID: 8049128 [Abstract] [Full Text] [Related]
4. Differential effects of estrogen and antiestrogen on transforming growth factor gene expression in endometrial adenocarcinoma cells. Gong Y, Ballejo G, Murphy LC, Murphy LJ. Cancer Res; 1992 Apr 01; 52(7):1704-9. PubMed ID: 1551100 [Abstract] [Full Text] [Related]
5. Effects of transforming growth factors and regulation of their mRNA levels in two human endometrial adenocarcinoma cell lines. Anzai Y, Gong Y, Holinka CF, Murphy LJ, Murphy LC, Kuramoto H, Gurpide E. J Steroid Biochem Mol Biol; 1992 Jun 01; 42(5):449-55. PubMed ID: 1616874 [Abstract] [Full Text] [Related]
6. Transforming growth factor-beta negatively modulates proliferation and c-fos expression of the human endometrial adenocarcinoma cell line HEC-1-A. Bergman CA, Talavera F, Christman GM, Baker VV, Roberts JA, Menon KM. Gynecol Oncol; 1997 Apr 01; 65(1):63-8. PubMed ID: 9103392 [Abstract] [Full Text] [Related]
7. Effects of sex steroids and growth factors on migration and invasion of endometrial adenocarcinoma SNG-M cells in vitro. Ueda M, Fujii H, Yoshizawa K, Abe F, Ueki M. Jpn J Cancer Res; 1996 May 01; 87(5):524-33. PubMed ID: 8641991 [Abstract] [Full Text] [Related]
8. [Effects of antiestrogens and medroxyprogesterone acetate on the clonogenic growth of tamoxifen-sensitive and resistant human breast cancer cells]. Nomura Y, Tashiro H, Takaeko F. Gan To Kagaku Ryoho; 1985 Apr 01; 12(4):844-50. PubMed ID: 3157351 [Abstract] [Full Text] [Related]
9. Growth stimulation and differential regulation of transforming growth factor-beta 1 (TGF beta 1), TGF beta 2, and TGF beta 3 messenger RNA levels by norethindrone in MCF-7 human breast cancer cells. Jeng MH, Jordan VC. Mol Endocrinol; 1991 Aug 01; 5(8):1120-8. PubMed ID: 1834933 [Abstract] [Full Text] [Related]
10. The expression and action of granulocyte macrophage-colony stimulating factor and its interaction with TGF-beta in endometrial carcinoma. Ripley D, Tang XM, Ma C, Chegini N. Gynecol Oncol; 2001 May 01; 81(2):301-9. PubMed ID: 11330966 [Abstract] [Full Text] [Related]
11. In vitro growth regulation of endometrial carcinoma cells by tamoxifen and medroxyprogesterone acetate. Grenman SE, Roberts JA, England BG, Grönroos M, Carey TE. Gynecol Oncol; 1988 Jun 01; 30(2):239-50. PubMed ID: 2967231 [Abstract] [Full Text] [Related]
12. Regulation of transforming growth factor alpha and transforming growth factor beta messenger ribonucleic acid abundance in T-47D, human breast cancer cells. Murphy LC, Dotzlaw H. Mol Endocrinol; 1989 Apr 01; 3(4):611-7. PubMed ID: 2524651 [Abstract] [Full Text] [Related]
13. Expression of growth factors and their receptors in human esophageal carcinomas: regulation of expression by epidermal growth factor and transforming growth factor alpha. Yoshida K, Kuniyasu H, Yasui W, Kitadai Y, Toge T, Tahara E. J Cancer Res Clin Oncol; 1993 Apr 01; 119(7):401-7. PubMed ID: 8491760 [Abstract] [Full Text] [Related]
14. Endogenous growth factor expression in T-47D, human breast cancer cells, associated with reduced sensitivity to antiproliferative effects of progestins and antiestrogens. Murphy LC, Dotzlaw H. Cancer Res; 1989 Feb 01; 49(3):599-604. PubMed ID: 2783382 [Abstract] [Full Text] [Related]
15. High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions. van den Berg HW, Martin J, Lynch M. Br J Cancer; 1990 Apr 01; 61(4):504-7. PubMed ID: 2139575 [Abstract] [Full Text] [Related]
16. Mechanisms involved in the evolution of progestin resistance in human breast cancer cells. Murphy LC, Dotzlaw H, Wong MS, Miller T, Murphy LJ. Cancer Res; 1991 Apr 15; 51(8):2051-7. PubMed ID: 1849041 [Abstract] [Full Text] [Related]
17. In vitro cytotoxicity of 4'-OH-tamoxifen and estradiol in human endometrial adenocarcinoma cells HEC-1A and HEC-1B. Cuevas ME, Lindeman TE. Oncol Rep; 2015 Jan 15; 33(1):464-70. PubMed ID: 25351552 [Abstract] [Full Text] [Related]
18. Transforming growth factor-beta activities in 'in vivo' lines of hormone-dependent and independent mammary adenocarcinomas induced by medroxyprogesterone acetate in BALB/c mice. Elizalde PV, Lanari C, Kordon E, Tezón J, Charreau EH. Breast Cancer Res Treat; 1990 Jul 15; 16(1):29-39. PubMed ID: 2145045 [Abstract] [Full Text] [Related]
19. Role of estrogen and estrogen-related growth factor in the mechanism of hormone dependency of endometrial carcinoma cells. Hata H, Hamano M, Watanabe J, Kuramoto H. Oncology; 1998 Dec 15; 55 Suppl 1():35-44. PubMed ID: 9852400 [Abstract] [Full Text] [Related]
20. Cytostatic effects of 3,3'-diindolylmethane in human endometrial cancer cells result from an estrogen receptor-mediated increase in transforming growth factor-alpha expression. Leong H, Firestone GL, Bjeldanes LF. Carcinogenesis; 2001 Nov 15; 22(11):1809-17. PubMed ID: 11698343 [Abstract] [Full Text] [Related] Page: [Next] [New Search]